PFD's therapeutic effects on IPF involve the antioxidant mechanism of suppressing BACH1 and enhancing NRF2.[422] BACH1 is also involved in pulmonary fibrosis through other mechanisms. Here, BACH1 is linked to polyostotic fibrous dysplasia.